-
Founded in:
1999-05-04 -
Country:
China -
Address:
Yichun Yuanzhou Pharmaceutical Industrial Park -
Tax NO.:
913609001609615995 -
Registered Funds:
91.25 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ammonium ferric citrate |
Iron is the main component of hemoglobin and myoglobin. It can accelerate the synthesis of hemoglobin and gradually correct the symptoms related to tissue iron deficiency and decreased activity of iron-containing enzymes.
More
Iron is the main component of hemoglobin and myoglobin. It can accelerate the synthesis of hemoglobin and gradually correct the symptoms related to tissue iron deficiency and decreased activity of iron-containing enzymes. |
2g | 1185-57-5 | 3 |
| Thiamine chloride |
It can maintain and improve gastrointestinal function.
More
It can maintain and improve gastrointestinal function. |
0.02g | 59-43-8 | 9 |
| Sodium 3-phosphoglycerate |
Iron is the main component of hemoglobin and myoglobin. Hemoglobin is the main oxygen carrier in red blood cells; myoglobin is the site where muscle cells store oxygen to help supply oxygen during muscle movement. Most enzymes and factors related to the tricarboxylic acid cycle contain iron, or can only function in the presence of iron. Therefore, active iron supplementation for iron-deficient patients can accelerate hemoglobin synthesis and gradually correct symptoms such as growth retardation, abnormal behavior, lack of physical strength, changes in mucosal tissues, and skin and nail lesions that are related to tissue iron deficiency and reduced iron-containing enzyme activity. Vitamin B1 has the effect of maintaining and improving gastrointestinal function.
More
Iron is the main component of hemoglobin and myoglobin. Hemoglobin is the main oxygen carrier in red blood cells; myoglobin is the site where muscle cells store oxygen to help supply oxygen during muscle movement. Most enzymes and factors related to the tricarboxylic acid cycle contain iron, or can only function in the presence of iron. Therefore, active iron supplementation for iron-deficient patients can accelerate hemoglobin synthesis and gradually correct symptoms such as growth retardation, abnormal behavior, lack of physical strength, changes in mucosal tissues, and skin and nail lesions that are related to tissue iron deficiency and reduced iron-containing enzyme activity. Vitamin B1 has the effect of maintaining and improving gastrointestinal function. |
0.2g | 17603-42-8 | 9 |
| Caffeine |
Iron is the main component of hemoglobin and myoglobin. Hemoglobin is the main oxygen carrier in red blood cells; myoglobin is the site where muscle cells store oxygen to help supply oxygen during muscle movement. Most enzymes and factors related to the tricarboxylic acid cycle contain iron, or can only function in the presence of iron. Therefore, active iron supplementation for iron-deficient patients can accelerate hemoglobin synthesis and gradually correct symptoms such as growth retardation, abnormal behavior, lack of physical strength, changes in mucosal tissues, and skin and nail lesions that are related to tissue iron deficiency and reduced iron-containing enzyme activity. Vitamin B1 has the effect of maintaining and improving gastrointestinal function.
More
Iron is the main component of hemoglobin and myoglobin. Hemoglobin is the main oxygen carrier in red blood cells; myoglobin is the site where muscle cells store oxygen to help supply oxygen during muscle movement. Most enzymes and factors related to the tricarboxylic acid cycle contain iron, or can only function in the presence of iron. Therefore, active iron supplementation for iron-deficient patients can accelerate hemoglobin synthesis and gradually correct symptoms such as growth retardation, abnormal behavior, lack of physical strength, changes in mucosal tissues, and skin and nail lesions that are related to tissue iron deficiency and reduced iron-containing enzyme activity. Vitamin B1 has the effect of maintaining and improving gastrointestinal function. |
0.08g | 0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| CARBETAPENTANE CITRATE |
It has central and peripheral antitussive effects, and its antitussive effect is about 1/3 of that of codeine. In addition to having a direct inhibitory effect on the respiratory center of the medulla oblongata, it also has a mild atropine-like effect. It can relax spasmodic bronchial smooth muscles and reduce airway resistance.
More
It has central and peripheral antitussive effects, and its antitussive effect is about 1/3 of that of codeine. In addition to having a direct inhibitory effect on the respiratory center of the medulla oblongata, it also has a mild atropine-like effect. It can relax spasmodic bronchial smooth muscles and reduce airway resistance. |
25mg | 23142-01-0 | 9 |
| Sucrose |
This product has central and peripheral antitussive effects, and its antitussive effect strength is about 1/3 of codeine. In addition to having a direct inhibitory effect on the respiratory center of the medulla oblongata, it also has a mild atropine-like effect. It can relax spasmodic bronchial smooth muscles and reduce airway resistance.
More
This product has central and peripheral antitussive effects, and its antitussive effect strength is about 1/3 of codeine. In addition to having a direct inhibitory effect on the respiratory center of the medulla oblongata, it also has a mild atropine-like effect. It can relax spasmodic bronchial smooth muscles and reduce airway resistance. |
6.5g | 57-50-1 | 71 |
| Citric acid monohydrate |
This product has central and peripheral antitussive effects, and its antitussive effect strength is about 1/3 of codeine. In addition to having a direct inhibitory effect on the respiratory center of the medulla oblongata, it also has a mild atropine-like effect. It can relax spasmodic bronchial smooth muscles and reduce airway resistance.
More
This product has central and peripheral antitussive effects, and its antitussive effect strength is about 1/3 of codeine. In addition to having a direct inhibitory effect on the respiratory center of the medulla oblongata, it also has a mild atropine-like effect. It can relax spasmodic bronchial smooth muscles and reduce airway resistance. |
5949-29-1 | 38 | |
| DL-Menthol |
This product has central and peripheral antitussive effects, and its antitussive effect strength is about 1/3 of codeine. In addition to having a direct inhibitory effect on the respiratory center of the medulla oblongata, it also has a mild atropine-like effect. It can relax spasmodic bronchial smooth muscles and reduce airway resistance.
More
This product has central and peripheral antitussive effects, and its antitussive effect strength is about 1/3 of codeine. In addition to having a direct inhibitory effect on the respiratory center of the medulla oblongata, it also has a mild atropine-like effect. It can relax spasmodic bronchial smooth muscles and reduce airway resistance. |
89-78-1 | 8 | |
| ethyl salicylate |
This product has central and peripheral antitussive effects, and its antitussive effect strength is about 1/3 of codeine. In addition to having a direct inhibitory effect on the respiratory center of the medulla oblongata, it also has a mild atropine-like effect. It can relax spasmodic bronchial smooth muscles and reduce airway resistance.
More
This product has central and peripheral antitussive effects, and its antitussive effect strength is about 1/3 of codeine. In addition to having a direct inhibitory effect on the respiratory center of the medulla oblongata, it also has a mild atropine-like effect. It can relax spasmodic bronchial smooth muscles and reduce airway resistance. |
118-61-6 | 14 | |
| Edible essence |
This product has central and peripheral antitussive effects, and its antitussive effect strength is about 1/3 of codeine. In addition to having a direct inhibitory effect on the respiratory center of the medulla oblongata, it also has a mild atropine-like effect. It can relax spasmodic bronchial smooth muscles and reduce airway resistance.
More
This product has central and peripheral antitussive effects, and its antitussive effect strength is about 1/3 of codeine. In addition to having a direct inhibitory effect on the respiratory center of the medulla oblongata, it also has a mild atropine-like effect. It can relax spasmodic bronchial smooth muscles and reduce airway resistance. |
0 | ||
| Caramel solution |
This product has central and peripheral antitussive effects, and its antitussive effect strength is about 1/3 of codeine. In addition to having a direct inhibitory effect on the respiratory center of the medulla oblongata, it also has a mild atropine-like effect. It can relax spasmodic bronchial smooth muscles and reduce airway resistance.
More
This product has central and peripheral antitussive effects, and its antitussive effect strength is about 1/3 of codeine. In addition to having a direct inhibitory effect on the respiratory center of the medulla oblongata, it also has a mild atropine-like effect. It can relax spasmodic bronchial smooth muscles and reduce airway resistance. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Folia perillae acutae |
|
0 | ||
| PEUCEDANI RADIX |
|
0 | ||
| Platycodonis Radix |
|
0 | ||
| ARMENIACAE SEMEN AMARUM |
|
0 | ||
| Ephedra |
|
0 | ||
| DGL |
|
0 | ||
| Citri reticulatae pericarpium |
|
0 | ||
| Pinellia ternata (processed) |
|
0 | ||
| Poria |
|
0 | ||
| Citrus aurantium (fried) |
|
0 | ||
| RADIX SCUTELLARIAE |
|
0 | ||
| Sucrose |
|
57-50-1 | 71 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| NOTOGINSENG RADIX ET RHIZOMA |
|
0 | ||
| Paeoniae Rubra |
|
0 | ||
| Citri Sarcodactylis Fructus |
|
0 | ||
| ALISMATIS RHIZOMA |
|
0 | ||
| DGL |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| NOTOGINSENG RADIX ET RHIZOMA |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
0 |